The CSI D-HF is a niche conference conducted in Frankfurt, Germany that presents the latest in heart failure intervention therapies and is attended by clinicians, industry and investors.  The Temporary Mechanical Circulatory support session, to which VenstraMedical was invited to present, featured the leading emerging technologies in the space.  Dr. Thambar highlighted the low-profile full flow VenstraMedical device and presented in-vitro and in-vivo data to support this claim.